Hybrid nanoparticle design based on cationized gelatin and the polyanions dextran sulfate and chondroitin sulfate for ocular gene therapy.
about
Nanomedicine in the application of uveal melanomaGelatin carriers for drug and cell delivery in tissue engineeringNanoparticle-based technologies for retinal gene therapyChondroitin sulfate-chitosan nanoparticles for ocular delivery of bromfenac sodium: Improved permeation, retention, and penetration.Non-viral therapeutic approaches to ocular diseases: An overview and future directionsNanoparticles in the ocular drug delivery.Current strategies for DNA therapy based on lipid nanocarriers.Gelatin-based particulate systems in ocular drug delivery.A sight on protein-based nanoparticles as drug/gene delivery systems.Smart Carriers and Nanohealers: A Nanomedical Insight on Natural PolymersGelatin-Based Materials in Ocular Tissue Engineering.siRNA-loaded liposomes: Inhibition of encystment of Acanthamoeba and toxicity on the eye surface.A nanomedicine to treat ocular surface inflammation: performance on an experimental dry eye murine model.
P2860
Q28079572-5891B027-D5C5-4FFA-B0C1-6670BFD0708DQ34079544-5C33A13D-8BA4-4A1C-9D6D-406D5C477FE1Q35843512-EE54353A-8A04-4A65-8AB5-40569B35D162Q35981514-71798D23-4741-4AEC-9536-FF3BE4BED316Q36425890-79A1D29B-438D-41D8-BC42-4A5E59AEE12EQ38119238-E4DAB67D-32BD-4E56-9E9F-E1B989B82A11Q38232143-DF21F879-C3A5-4F42-8FB0-8BD12ADAA838Q38310627-DBF98847-2ED1-4169-952A-F557E3015007Q38573478-CE3854FE-E116-43A8-83F3-83A7DAED3CF2Q38630726-B9FA22A4-9B9F-434F-8AAF-B080F241EEC8Q39209355-51AFA439-EFBB-4445-B777-C0C79FE33A93Q40353236-E1AECA71-CA8F-45B0-B876-54CB0751EA68Q45880556-EE9C40D8-C770-4D1A-AFBE-8A7B30C51950
P2860
Hybrid nanoparticle design based on cationized gelatin and the polyanions dextran sulfate and chondroitin sulfate for ocular gene therapy.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Hybrid nanoparticle design bas ...... lfate for ocular gene therapy.
@en
Hybrid nanoparticle design bas ...... lfate for ocular gene therapy.
@nl
type
label
Hybrid nanoparticle design bas ...... lfate for ocular gene therapy.
@en
Hybrid nanoparticle design bas ...... lfate for ocular gene therapy.
@nl
prefLabel
Hybrid nanoparticle design bas ...... lfate for ocular gene therapy.
@en
Hybrid nanoparticle design bas ...... lfate for ocular gene therapy.
@nl
P2093
P2860
P356
P1476
Hybrid nanoparticle design bas ...... lfate for ocular gene therapy.
@en
P2093
Alejandro Sánchez
Begoña Seijo
Giovanni Konat Zorzi
Jenny Evelin Párraga
P2860
P304
P356
10.1002/MABI.201100005
P577
2011-04-08T00:00:00Z